Skip to main navigation Skip to search Skip to main content

Studies in the Area of Breast Cancer Reported from Johns Hopkins University School of Medicine (Entinostat, Nivolumab and Ipilimumab for Women With Advanced Her2-negative Breast Cancer: a Phase Ib Trial)

Press/Media

Period12 Mar 2024

Media coverage

1

Media coverage

  • TitleStudies in the Area of Breast Cancer Reported from Johns Hopkins University School of Medicine (Entinostat, Nivolumab and Ipilimumab for Women With Advanced Her2-negative Breast Cancer: a Phase Ib Trial)
    Media name/outletNewsRx Women's Health Daily
    Country/TerritoryUnited States
    Date12/03/24
    PersonsRoisin Connolly